Search

Issue
Title
Authors
Survival analysis of patients with advanced metastatic differentiated thyroid cancer
Borodavina E.V., Shurinov A.Y., Krylov V.V., Vasilev K.G.
Влияние прерывания терапии ленватинибом на общую эффективность лечения у пациентов с радиойодрезистентным дифференцированным раком щитовидной железы в исследовании III фазы
Tahara M., Brose M.S., Wirth L.J., Suzuki T., Miyagishi H., Fujino K., Dutcus C.E., Gianoukakis A.
Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States
Worden F., Rajkovic-Hooley O., Reynolds N., Milligan G., Zhang J.
A randomized study to evaluate the safety and efficacy of two dosages of lenvatinib – 18 and 24 mg – in patients with radioiodrefract differentiated thyroid cancer
Brose M.S., Panaseykin Y., Konda B., de la Fouchardiere C., Hughes B.G., Gianoukakis A.G., Park Y.J., Romanov I., Krzyzanowska M.K., Leboulleux S., Binder T.A., Dutcus C., Xie R., Taylor M.H.
Prolonged duration of response in lenvatinib responders with thyroid cancer (Russian translation)
Gianoukakis A.G., Dutcus C.E., Batty N., Guo M., Baig M.
Advanced metastatic radioiodine refractory differentiated thyroid cancer: current treatment and dynamic surveillance issues
Borodavina E.V., Shurinov A.Y., Krylov V.V.
Historical aspects and modern concepts in the treatment of patients with differentiated thyroid cancer, refractory to radioactive iodine therapy
Borodavina E.V., Krylov V.V., Isaev P.A., Shurinov A.Y., Rodichev A.A.
Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial
Brose M.S., Worden F.P., Newbold K.L., Guo M., Hurria A.
Lenvatinib in advanced radioiodine-refractory differentiated thyroid cancer: what’s new?
Borodavina E.V., Kutukova S.I., Shurinov A.Y., Krylov V.V.
Personalized therapy with lenvatinib for progressive radioiodine refractory differentiated thyroid cancer in routine clinical practice
Rumyantsev P.O., Borodavina E.V., Kutukova S.I., Vasilyeva E.B.
LENVATINIB IN TREATMENT OF RADIOACTIVE IODINE-REFRACTORY WELL-DIFFERENTIATED THYROID CARCINOMA
Romanov I.S., Mudunov A.M., Isaev P.A., Bychkov Y.M., Dolgushin M.B., Odzharova A.A., Romanova L.F.
Positive results of treatment of adenocystic carcinoma of the parotid salivary gland with lenvatinib
Filippov I.A., Shvedsky M.S., Gaisina E.A., Bakhova L.A.
Tall-cell variant of papillary thyroid carcinoma: literature review and case reports
Borodavina E.V., Isaev P.A., Sevrukov F.S., Sidorin A.V., Polkin V.V., Ilyin A.A., Severskaya N.V., Agababyan T.A., Ivanov S.A., Kaprin A.D.
Clinical experience in using lenvatinib in patients with progressive, radioactive iodine-refractory differentiated thyroid cancer
Isaev P.A., Semin D.Y., Rumyantsev P.O., Il’in A.A., Pol’kin V.V., Agababyan T.A., Vasil’kov S.V., Medvedev V.S., Zhelonkina N.V.
Observation and treatment of patients with progressive metastatic differentiated thyroid cancer after establishment of radioiodine refractoriness
Borodavina E.V., Kutukova S.I., Shurinov A.Y., Vasil’eva E.B., Guz A.O., Grishkevich I.V., Karateeva S.D., Shakhmatova A.R., Slobodyanskiy R.S., Romanchuk O.V., Mukhitova M.R., Karpovich M.P., Dmitriev S.P., Saypeeva O.S., Tolpeykina K.A., Tolstov S.S., Makarova A.V., Tyugina Y.A., Ovchinnikova E.G.
Specificity of hand-foot skin reaction induced by multikinase inhibitors: clinical, histological and ultrasound characteristics
Shatokhina E.A., Potkin S.B., Malkov P.G., Kruglova L.S., Polonskaya A.S.
New-generation mutitargeted tyrosine kinase inhibitors in the treatment of radioactive iodine-refractory differentiated thyroid cancer
Mudunov A.M.
Clinical experience in the neoadjuvant treatment of unresectable differentiated thyroid cancer with the lenvatinib
Vasilyeva E.B., Rostovtsev D.M., Tolpeikina К.A., Fatkullin D.M., Guz A.О.
Efficacy and tolerability of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer: results of a multicenter observational study in the Russian Federation
Borodavina E.V., Isaev P.A., Shurinov A.Y., Rumyantsev P.O., Krylov V.V., Petrosyan K.M., Kaprin A.D., Ivanov S.A., Podvyaznikov S.O., Romanov I.S., Mudunov A.M., Slashchuk K.Y., Zhikhorev R.S., Volkonsky M.V., Chagova R.M., Suslova I.R., Khryapa A.I., Lepshokova A.K., Fadeeva N.L., Safarova A.R., Kaleykina L.P., Lymar E.V., Chernyakova E.M., Snezhko O.A., Zinkovskaya A.E., Mufazalov F.F., Kuzmina E.S., Druzhinina Y.V., Musin S.I., Mukhitova M.R., Khasanova A.I., Safina S.Z., Kirienko S.L.
Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit
Wirth L.J., Durante C., Topliss D.J., Winquist E., Robenshtok E., Iwasaki H., Luster M., Elisei R., Leboulleux S., Tahara M.
Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer
Cabanillas M.E., Takahashi S.
1 - 21 of 21 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"